{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:33Z","timestamp":1761058293009},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00120-005-0839-z","type":"journal-article","created":{"date-parts":[[2005,6,7]],"date-time":"2005-06-07T09:38:37Z","timestamp":1118137117000},"page":"915-917","source":"Crossref","is-referenced-by-count":2,"title":["\u201eSecond-line-Polychemotherapie\u201c beim metastasierten Urothelkarzinom des Nierenbeckens"],"prefix":"10.1007","volume":"44","author":[{"given":"A.","family":"Bannowsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Wefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-P.","family":"J\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"839_CR1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s001200170005","volume":"40","author":"Hauser","year":"2001","unstructured":"Hauser S, Studer UE (2001) Therapie des Nierenbeckenkarzinoms. Urologe A 40: 452\u2013455","journal-title":"Urologe A"},{"key":"839_CR2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","volume":"164","author":"Munoz","year":"2000","unstructured":"Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5): 1523\u20131525","journal-title":"J Urol"},{"key":"839_CR3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1570-9124(03)00019-9","volume":"1","author":"Sternberg","year":"2003","unstructured":"Sternberg CN (2003) Metastatic bladder cancer: Role of chemotherapy and new agents. EAU Update Series 1(2): 108\u2013117","journal-title":"EAU Update Series"},{"key":"839_CR4","first-page":"18","volume":"26","author":"Lehmann","year":"2003","unstructured":"Lehmann J, Retz M, Hack M, Siemer S, St\u00f6ckle M (2003) Systemische Chemotherapie des Urothelkarzinoms. Onkologie 26(Suppl 4): 18\u201325","journal-title":"Onkologie"},{"key":"839_CR5","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.2004.09.043","volume":"22","author":"Bamias","year":"2004","unstructured":"Bamias A, Deliveliotis C, Fountzilas G et al. (2004) Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol 22(11): 2150\u20132154","journal-title":"J Clin Oncol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0839-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-005-0839-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-005-0839-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:54:02Z","timestamp":1558594442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-005-0839-z"}},"subtitle":["Andauernde partielle Remission nach 18\u00a0Kursen Gemcitabin\/Paclitaxel trotz 24\u00a0Kursen Gemcitabin\/Cisplatin im \u201estable disease\u201c"],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["839"],"URL":"https:\/\/doi.org\/10.1007\/s00120-005-0839-z","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}